CRISPR-Cas9 targeted deletion of the <i>C9orf72</i> repeat expansion mutation corrects cellular phenotypes in patient-derived iPS cells
Mochtar Pribadi(Fate Therapeutics (United States)), Giovanni Coppola(Regeneron (United States))
Cited by 14
Related Papers
Required growth facilitators propel axon regeneration across complete spinal cord injury
|Nature|2018|535
Astrocyte layers in the mammalian cerebral cortex revealed by a single-cell in situ transcriptomic map
|Nature Neuroscience|2020|505